3 results match your criteria: "The Cancer Center of Long Island[Affiliation]"
Int Immunopharmacol
March 2003
Division of Medical Oncology, The Department of Medicine, The Cancer Center of Long Island, Stony Brook, NY, USA.
The expression and cell surface levels of many important receptors are dependent on the maturation stage of dendritic cells (DCs), and related to the unique function of immature and mature DCs. In this report, we show for the first time that human monocyte-derived DCs express two types of C1q-receptors, gC1qR and cC1qR. Furthermore, immature DCs secrete detectable amount of C1q into the culture supernatant.
View Article and Find Full Text PDFCancer Immunol Immunother
February 2003
The Cancer Center of Long Island, Stony Brook, NY, USA.
Dendritic cells (DC) loaded with tumor associated antigens (TAA) are often used for the vaccination of cancer patients; however methodologies for the vaccine preparation have not yet been standardized. The purpose of this work was to optimize the ex-vivo production of functional TAA-loaded DC that would produce interleukin-2 (IL-12) and enhance the T cell response. We generated ex-vivo DC from human monocytes with granulocyte macrophage-colony stimulating factor (GM-CSF) and IL-4, and whole necrotic tumor cells (cell lysates) of cancer cell lines were used as model TAA.
View Article and Find Full Text PDFInt Immunopharmacol
January 2003
Department of Medicine, Division of Medical Oncology, The Cancer Center of Long Island, State University of New York, Stony Brook, NY, USA.
The expression and cell surface levels of many important receptors are dependent on the maturation stage of dendritic cells (DCs), and related to the unique function of immature and mature DCs. In this report, we show, for the first time, that human monocyte-derived DCs express two types of C1q receptors, gC1qR and cC1qR. Furthermore, immature DCs secrete detectable amount of C1q into the culture supernatant.
View Article and Find Full Text PDF